Ketkar says the lawsuit, filed in New York, sought to correct the rights to inventorship on key patents for Arista’s high-amylose wheat. With this, Arcadia is moving forward with its GoodWheat portfolio towards commercialization.
Investor deep dive
Arcadia Biosciences blossoms into a health-conscious ingredients company
Arcadia Biosciences announces end of patent lawsuit against Arista Cereal Technologies
Quick facts: Arcadia Biosciences Inc
Market Cap: $41.61 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...FOR OUR FULL DISCLAIMER CLICK HERE